Eshoo, Bipartisan House Leaders Introduce Legislation to Provide Emergency Funding for Federal Researchers

June 25, 2020
Press Release

WASHINGTON, D.C. – Today, Health Subcommittee Chairwoman Anna G. Eshoo (CA-18) announced the introduction of the Research Investment to Secure the Economy (RISE) Act, legislation providing $26 billion in emergency funding for federal science agencies to ensure researchers can continue their critical work on federally-funded research projects during the COVID-19 pandemic. The legislation was introduced with a bipartisan group of House lawmakers, including Representatives Diana DeGette (D-CO), Fred Upton (R-MI), Eddie Bernice Johnson (D-TX), Frank D. Lucas (R-OK), and Anthony Gonzalez (R-OH).

“The COVID-19 pandemic has shuttered our nation’s preeminent research institutions and ground to a halt the important work being done by some of the best and brightest minds across the country,” said Rep. Eshoo. “The U.S. is the global leader in scientific research and innovation but without emergency funding to keep these projects going, we risk missing the next great breakthrough and losing our competitive edge. The RISE Act will breathe new life into federally-funded research projects and enable our nation’s brilliant researchers to continue their critical work.”

“America’s great research universities are the engine of economic progress in our country. The RISE Act provides the investment necessary to re-start the nation’s research enterprise, which will fuel economic progress and drive the innovations that underpin advancements in health, jobs, and security. This bill will not only ensure that the federally funded research already in progress at Stanford and across the nation can be completed, but that the advancement of discovery and innovation can continue without further delay.” - Marc Tessier-Lavigne, President, Stanford University

"If we are going to remain the world's leader in innovation, our research workforce— including graduate and postdoctoral students— must have the tools they need to continue playing a vital role in developing the next generation of technologies and cures. Ramping up research to pre-COVID-19 levels is vital to preserving and advancing research and innovation solutions for the immediate and long-term needs of this nation. In a situation as unprecedented as the one now facing, our nation is dangerously close to ceding U.S. leadership of the world’s technology enterprise. The RISE Act will ensure we continue to be a world leader in innovation." - Janet Napolitano, President, University of California System

Background

The RISE Act authorizes $26 billion in emergency funding for federal science agencies, including the Department of Health and Human Services; the Department of Agriculture; the Department of Energy; the Environmental Protection Agency; the National Science Foundation (NSF), to award to research universities, independent institutions, and national laboratories to continue federally supported research projects.

The funding will enable graduate students, post-doctoral researchers, and Principal Investigators to complete work that was disrupted by COVID-19, or extend the training or employment of researchers on an existing research project for up to two years because of disruptions to the job market. The RISE Act would also allow federal agencies to award research grants and cooperative agreements to colleges or universities to conduct research on the behavioral, social or economic effects of COVID-19 and the responses to the disease.

Text of the legislation can be found HERE.

###